M
Michael Hughes
Researcher at Royal Hallamshire Hospital
Publications - 615
Citations - 26328
Michael Hughes is an academic researcher from Royal Hallamshire Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 74, co-authored 531 publications receiving 24066 citations. Previous affiliations of Michael Hughes include Royal College of Physicians & St Thomas' Hospital.
Papers
More filters
Journal ArticleDOI
External-beam treatment planning on a time-sharing graphics terminal system
TL;DR: A graphics terminal system has been developed to facilitate interaction capabilities during external-beam treatment planning on time-shared computers and may be added over time without compromising the objectives of the planning process.
Journal ArticleDOI
Methylene-blue aided rapid confocal laser endomicroscopy of breast cancer
TL;DR: A custom high-speed line-scan confocal laser endomicroscopy system at 660 nm that enables high-resolution histomorphological imaging of breast tissue stained with methylene-blue, an alternative fluorescent stain for localizing sentinel nodes during breast surgery is described.
Proceedings ArticleDOI
A balloon endomicroscopy scanning device for diagnosing barrett's oesophagus
TL;DR: The experimental results demonstrate the potential of the robotic catheter for systematic high-resolution imaging of the oesophageal mucosa, potentially reducing or even eliminating the need for physical biopsy.
Journal ArticleDOI
What narrative devices do people with systemic sclerosis use to describe the experience of pain from digital ulcers: a multicentre focus group study at UK scleroderma centres.
Jennifer Jones,Jennifer Jones,Michael Hughes,Michael Hughes,John D Pauling,John D Pauling,Rachael Gooberman-Hill,Rachael Gooberman-Hill,Andrew Moore +8 more
TL;DR: The experience of SSc-DU pain leads to the use of graphic language and rich description by participants in the focus group setting, and will hopefully support the development of a novel PROM to assess the severity and impact of S Sc-DUs.
Journal ArticleDOI
Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection
Julie Boucau,Kara W. Chew,Manish Chandra Choudhary,Rinki Deo,James Regan,James P Flynn,Charles R Crain,Michael Hughes,Justin Ritz,Carlee Moser,Joan Dragavon,Arzhang Javan,Ajay Nirula,Paul Klekotka,Alexander L. Greninger,Robert W. Coombs,William A. Fischer,Eric S. Daar,David A. Wohl,Joseph J. Eron,Judith S. Currier,Davey M. Smith,Jonathan Z. Li,Amy K. Barczak +23 more
TL;DR: In this paper , the authors show that the use of mAbs can significantly improve the clearance of culturable SARS-CoV-2 Omicron-type viruses. But, they do not show that mAbs may offer immediate (household) and public health benefits by reducing onward transmission.